Prognostic Impact of the Location of Mitral Valve Prolapse on the Long-term Results of Mitral Plasty

Mitral insufficiency (MI) accounts for 24% of adult valvulopathies and affects 7% of subjects older than 75 years. They are the second leading cause of valvulopathy in Europe. The most common etiology is the associated valvular prolapse. Mitral surgery remains the reference treatment for symptomatic MI. The success of this procedure depends on the mitral valve geometry and the location of the prolapse. The site of the prolapse, whether monovalvular, localized to the posterior or anterior leaflet, or bivalvular, influences the possibilities and probably the long-term results of the plasty.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Mitral Valve Prolapse Cardiovascular Diseases Heart Diseases Heart Valve Diseases Heart Valve Prolapse Mitral Plasty

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU Amiens Picardie

Amiens, Picardie, 80054, France

Location status: Recruiting

Location contact

Catherine SZYMANSKI, Dr

CONTACT

[email protected]

+33322455885

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients operated between 1988 and 2011
Presence of a valvular prolapse diagnosed by echocardiography
Possibility of a complete clinical evaluation at the time of the initial echocardiography

Exclusion criteria

Ischemic MI (including papillary muscle rupture)
Presence of significant aortic valvulopathy, mitral valvular stenosis or congenital disease
History of cardiac surgery

Treatment and study plan

Primary outcomes

Survival defines as the time between the date of surgery and the death or date of the last news

Time frame: 6 months

Study contacts

Contact information is provided by the study sponsor or research team.

Catherine SZYMANSKI, Dr

CONTACT

[email protected]

+33322455885

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire, Amiens

Other

Registry information

Acronym: IPPVM

Important dates

Study start: 2013
Primary completion: 2028
Study completion: 2028
First posted: Apr 13, 2017
Registry last updated: May 23, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting